10-K Decoder · All companies

Editas Medicine, Inc.

EDIT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$40.5M$32.3M+25.4%
Operating income−$160M−$251M+36.3%
Net income−$160M−$237M+32.5%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$10.4M$7.50M+38.7%
Operating income−$24.3M−$24.5M+0.8%
Net income−$23.4M−$25.1M+6.8%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Editas Medicine's revenue in FY2025?
$40.5M in FY2025 (Fiscal year ended Dec 31, 2025), +25.4% vs $32.3M a year earlier, per its 10-K filed Mar 2026.
Was Editas Medicine profitable in FY2025?
No: net income was −$160M and operating income −$160M in FY2025.
What was Editas Medicine's revenue in Q3 2026?
$10.4M (+38.7% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.